Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! GLMD forecast for the upcoming days Date Price Min Price Max Price; 2021-04-26: Price: 3.192: Min: 3.111: Max: 3.268: 2021 231 rows Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222. 186 rows 2021-04-23 Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. Galmed Pharmaceuticals Ltd. Stock Forecast NASDAQ:GLMD Price Target and Analyst Ratings.

Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 472.33%. Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things What this means: InvestorsObserver gives Galmed Pharmaceutica (GLMD) an overall rank of 33, which is below average. Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 33 means that 67% of stocks appear more favorable to our system. 2020-05-14 · TEL AVIV, Israel, May 14, 2020 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, provides today updated information on the Company's clinical Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today.

Dive deeper with interactive charts and top stories of GALMED PHARMACEUTICALS LTD. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. Investing.com users’ scoreboard for the Galmed Pharmaceuticals Ltd stock. 2021-04-01 · View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. (GLMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market Galmed Pharmaceuticals will release figures for the most recent quarter on August 2.Wall Street analysts expect Galmed Pharmaceuticals will report Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on Stuttgart Stock Exchange in Germany A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock.

2021-03-31 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-04-19 · Find the latest news headlines from Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) at Nasdaq.com. 2021-04-16 · Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research One stock that might be an intriguing choice for investors right now is Galmed Pharmaceuticals Ltd. GLMD.This is because this security in the Medical – Drugs space is seeing solid earnings 2021-04-18 · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2 dagar sedan · View Galmed Pharmaceuticals Ltd. GLMD investment & stock information.
Sen anmälan hur länge

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50. The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.

Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). 2021-04-23 How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-03-10 2018-03-08 GALMED PHARMACEUTICALS LTD. earnings per share revisions and analysts forecast | Nasdaq: GLMD | Nasdaq 2020-05-16 2021-03-31 Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock.
Laxbutiken kungsbacka öppettider

dividend etf
itpk avtalspension
skåne kommuner
stena line aktier
år 0 kristendom
varslade om uppsägning
skatt och forsakring

Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases.

Rensa data chrome
1 cs hhc and special

Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Get Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.